Results 211 to 220 of about 3,084 (231)

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Effect of the carboxyl terminus of the human VIP2 receptor (VPAC2) on receptor affinity, adenylate cyclase activation and receptor internalization

Gastroenterology, 2001
H IGARASHI, W HOU, T ITO, T PRADHAN, S MANTEY, D COY, R JENSEN   +6 more
openaire   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Involvement of VPAC1 and VPAC2 Receptors in Increasing Local Pancreatic Blood Flow in Anesthetized Rats

Pancreas, 2008
Hisato, Igarashi, Tetsuhide, Ito, Mizuho, Kuwano-Kojima, Ryoichi, Takayanagi, David H, Coy, Robert T, Jensen   +5 more
openaire   +2 more sources

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Targeting receptor complexes: a new dimension in drug discovery

Nature Reviews Drug Discovery, 2020
Mette Ishøy Rosenbaum, Louise Albertsen, David S Bredt   +2 more
exaly  

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Nature Reviews Drug Discovery, 2011
Uwe Rudolph
exaly  

Development of subtype-selective oestrogen receptor-based therapeutics

Nature Reviews Drug Discovery, 2011
Jan-Ake Gustafsson
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly